{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:43:33Z","timestamp":1773276213118,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ejogrb.2005.11.019","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T10:21:35Z","timestamp":1135074095000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome"],"prefix":"10.1016","volume":"126","author":[{"given":"M.","family":"Mitkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pehlivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Terzieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2005.11.019_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2003.01842.x","article-title":"The pathophysiology of polycystic ovary syndrome","volume":"60","author":"Tsilchorozidou","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib3","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib4","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.ajog.2004.02.052","article-title":"The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis","volume":"190","author":"Mor","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/jc.2004-0410","article-title":"Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients","volume":"90","author":"Ciampelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2001.01303.x","article-title":"Tissue insulin sensitivity and body weight in polycystic ovary syndrome","volume":"55","author":"Marsden","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib7","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"de Leo","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib10","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome","volume":"19","author":"Kashyap","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Velazquez","year":"1997","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2337\/diabetes.54.2.333","article-title":"Identification of individuals with insulin resistance using routine clinical measurements","volume":"54","author":"Stern","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib16","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1210\/jc.2002-020557","article-title":"Biological variation of free androgen index and bioavailable testosterone in PCOS: implications for estimation of hyperandrogenaemia","volume":"88","author":"Jayagopal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","article-title":"Current concepts in the polycystic ovary syndrome","volume":"52","author":"Dunaif","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/humrep\/deh329","article-title":"Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third to fourth-generation OC reduces body adiposity","volume":"19","author":"Ibanez","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2003.08.024","article-title":"Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome","volume":"81","author":"Belli","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepilian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib21","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib22","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib23","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2004.04.003","article-title":"Glitazones and the management of insulin resistance: what they do and how might they be used","volume":"33","author":"Einhorn","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diacare.25.4.708","article-title":"A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone","volume":"25","author":"Khan","year":"2002","journal-title":"Diab Care"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/humrep\/deh700","article-title":"Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study","volume":"20","author":"Kilicdag","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2005.11.019_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2004.06.035","article-title":"Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome","volume":"118","author":"Mitkov","year":"2005","journal-title":"Eur J Obstetr Gynecol Reprod Biol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505006470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505006470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:29Z","timestamp":1759554929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505006470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0301211505006470"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.11.019","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}